GENE ONLINE|News &
Opinion
Blog

Ruchi Jhonsa

WRITTEN BY Ruchi Jhonsa

Bristol Myers Squibb Registers Another Trial Win for its Psoriasis Med
2021-02-03
Horizon Buys AstraZeneca Spinout for $3 Billion to Broaden Rare Disease Pipeline
2021-02-02
Lilly Teams up with GSK, Vir to Fight New COVID-19 Variants Using Antibody Combo
2021-01-28
Moderna Applies Two-Pronged Strategy to Fight against Coronavirus Variants 
2021-01-26
Another Checkpoint Inhibitor Set to Make Market Appearance as FDA Grants Priority Review
2021-01-25
Biohaven’s Troriluzole Joins Long List of Failed Alzheimer’s Drugs
2021-01-21
Merck and Bayer Enter the Congested Market of Heart Failure with Verquvo
2021-01-21
FDA Greenlights Pfizer’s Xalkori for a Rare Form of Non-Hodgkin Lymphoma
2021-01-19
Key Takeaways from the JPM Healthcare Conference: Gilead, Regeneron Lay Oncology Plans, Merck Looks Beyond Keytruda
2021-01-17
Alnylam Aims to Obtain “Top 5 Biotech” Tag By 2025
2021-01-12
Alnylam Nears Fourth Approval with Successful Trial Data for RNAi Drug
2021-01-08
Investors Bet $120 Million on Ikena Oncology’s Cancer Therapies
2021-01-06
AstraZeneca, Bharat Biotech Vaccines Nab Emergency Approval in India
2021-01-04
Voyager Encounters Regulatory Bump in Parkinson’s Trial
2020-12-25
A 11-Year-Old, Survivor-Derived Antibody Becomes Second Ebola Therapy to Bag FDA Approval
2020-12-23
1 2 3 4 5 13
Scroll to Top